Baird lowered the firm’s price target on Emerson (EMR) to $130 from $140 and keeps a Neutral rating on the shares. The firm updated its model following Q1 results where it showed strong operational and order momentum in an uncertain environment.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- Emerson price target raised to $127 from $119 at Citi
- Emerson price target raised to $104 from $99 at Barclays
- Strong Financial Performance and Strategic Decisions Drive Buy Rating for Emerson Electric
- Emerson Electric Reports Strong Q2 2025 Results
- Emerson Electric Reports Strong Q2, Positive Outlook